PharmaTher Develops Colon-Targeted KPV and BPC-157 Products
PharmaTher says it is developing colon-targeted KPV and BPC-157 products for a new US peptide pathway.
PharmaTher says it is developing colon-targeted KPV and BPC-157 products for a new US peptide pathway.